Opportunity ID: 118333

General Information

Document Type:: Grants Notice
Funding Opportunity Number:: DARPA-BAA-11-71
Funding Opportunity Title:: Biologically-derived Medicines on Demand
Opportunity Category:: Discretionary
Opportunity Category Explanation::
Funding Instrument Type::
Category of Funding Activity:: Science and Technology and other Research and Development
Category Explanation::
Expected Number of Awards::
Assistance Listings Number(s):: 12.910 — Research and Technology Development
Cost Sharing or Matching Requirement:: No
Version:: Synopsis 2
Posted Date:: Aug 30, 2011
Last Updated Date:: Sep 09, 2011
Original Closing Date for Applications:: Nov 15, 2011
Current Closing Date for Applications:: Sep 09, 2011
Archive Date:: Sep 12, 2011
Estimated Total Program Funding::
Award Ceiling:: $
Award Floor:: $

Eligibility

Eligible Applicants:: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility::

Additional Information

Agency Name:: DARPA – Defense Sciences Office
Description:: The Bio-MOD program seeks to develop devices and techniques to produce multiple protein biologics in response to specific battlefield threats and medical needs. This will be achieved by investing in (1) novel, flexible methodologies for genetic engineering/modification of microbial strains, eukaryotic strains, and/or cell-free systems to synthesize multiple protein-based therapeutics; and (2) flexible and portable device platforms for manufacturing multiple biologics with high purity, efficacy and potency at the point-of-care, in short timeframes, when the specific need arises. Consequently, Bio-MOD will provide a battlefield medical supply for military medics at the front lines of support that is responsive to far-forward emergency settings and emergent in-theater needs.
Link to Additional Information::
Grantor Contact Information:: If you have difficulty accessing the full announcement electronically, please contact:

Version History

Version Modification Description Updated Date
Synopsis 2 The purpose of this Modification 1 to DARPA-BAA-11-71 Biologically-derived Medicines on Demand (Bio-MOD) is to cancel the BAA. Proposal Abstracts and Full Proposals are no longer being requested. Sep 09, 2011
Synopsis 1

Package Status

Below are CLOSED Opportunity Package(s) no longer available for this Funding Opportunity:

Package No: 1

Packages

Assistance Listings Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions Who Can Apply:
12.910 PKG00075350 Aug 30, 2011 Sep 10, 2011 View BAA Coordinator Organization and Individual Applicants